Continuous glucose monitors for adults with diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests two continuous glucose monitors (CGMs) worn on the arm to see how accurate and safe they are. A CGM is a small device that checks your blood sugar levels without finger pricks. The trial lasts about 17 days and involves wearing two sensors at the same time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have type 1 or type 2 diabetes that was diagnosed at least 6 months ago.
- If you have type 1 diabetes, you must have used a continuous glucose monitor before.
- You need to be willing to wear two sensors on your arm for 17 days and attend six clinic visits.
- You cannot be pregnant or have recent skin issues where the sensor is placed.
- You should not be taking certain medications (like high-dose vitamin C or blood thinners) that could affect the sensor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new continuous glucose monitor (a small sensor that checks blood sugar levels) to see how well and safely it works in people with type 1 diabetes. You'll wear the sensor for 15 days and attend three clinic visits to check its accuracy against blood samples.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
This trial tests a new continuous glucose monitor that checks blood sugar levels without frequent finger pricks. It aims to see how accurate and safe it is for people with type 1 diabetes.
This trial tests if using a continuous glucose monitor (CGM) helps older adults with type 2 diabetes who are not on insulin to better control their blood sugar. The results will show if CGM is a helpful tool for managing diabetes without daily shots.
This study tests a new continuous glucose monitor (CGM) that you wear for 14 days. It checks how accurate the device is and how well it helps track your blood sugar levels, all while being safe and easy to use.
This study tests a new continuous glucose monitor (CGM) that checks your sugar levels day and night without frequent finger pricks. It may help you manage your diabetes better by showing glucose trends and alerts.
Hear when a new Diabetes Mellitus, Type 1 | Diabetes Mellitus, Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.